Drugs · acquisition-cost intelligence
Naloxone Hydrochloride
Naloxone· ingredient naloxonePeripheral opioid receptor antagonists· NALOXONE HYDROCHLORIDE 4 mg/.1mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$17.66
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per EA — the trend nobody else shows. 9 weeks.
2025-01-222026-06-03
Same-ingredient options by acquisition cost
Other naloxone products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.
| Product | NADAC / EA | vs this |
|---|---|---|
| Pentazocine and naloxone | $2.02 | −$15.64 |
| Naloxone Hydrochloride | $4.38 | −$13.28 |
| Naloxone Hydrochloride | $4.38 | −$13.28 |
| naloxone hydrochloride | $13.43 | −$4.23 |
| KLOXXADO | $59.75 | +$42.09 |
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.